Buscar en
European Journal of Psychiatry
Toda la web
Inicio European Journal of Psychiatry Comparison of inflammation markers and severity of illness among patients with C...
Journal Information
Vol. 37. Issue 2.
Pages 125-132 (April - June 2023)
Share
Share
Download PDF
More article options
ePub
Vol. 37. Issue 2.
Pages 125-132 (April - June 2023)
Original article
Comparison of inflammation markers and severity of illness among patients with COVID-19, acute psychiatric disorders and comorbidity
Visits
1148
Özgecan Tunaa,
Corresponding author
ozgecantuna@gmail.com

Corresponding author.
, Cagatay Ermisb, Asli Enez Darcinc, Ekin Dagistand, Serdar Salmand
a Department of Psychiatry, Kanuni Sultan Süleyman Training and Research Hospital, Turkey
b Department of Child and Adolescent Psychiatry, Diyarbakır Childrens' Hospital, Turkey
c İstanbul Ayvansaray University, Turkey
d Department of Psychiatry, Istanbul Bakirkoy Prof Dr. Mazhar Osman Ruh Mental and Nervous Diseases Training and Research Hospital, Turkey
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Background and objectives

Neutrophil, lymphocyte counts, lactate dehydrogenase (LDH), D-dimer, fibrinogen, and comorbid illness are associated with the course and prognosis of COVID-19. However, the course of acute severe psychiatric disorders overlapping with COVID-19 infection was not investigated and remained as an unclarified research area. This study aimed to demonstrate inflammatory markers and the course of patients suffering from both conditions.

Methods

Thirty-eight inpatients with COVID-19 and comorbid acute psychiatric disorders (COVID-19+PD), 31 inpatients with COVID-19, and 38 inpatients with an acute psychiatric disorder (PD) were included in the study. Neutrophil, lymphocyte counts, serum ferritin, lactate dehydrogenase (LDH), D-dimer, fibrinogen, Systemic immune-inflammation index (SII), neutrophil/lymphocyte ratio (NLR), and C-reactive protein (CRP) were compared to evaluate inflammation levels.

Results

Patients with SARS-CoV-2 infection had older age compared to the PD group. CALL (Comorbidity, age, lymphocyte, lactate dehydrogenase) scores which predict the progression risk in patients with COVID-19 pneumonia, of both COVID-19 groups were found similar. The COVID-19+PD had higher SII in the study sample. Additionally, the COVID-19+PD group had higher NLR, ferritin, and CRP levels than those of the PD group.

Conclusions

The prognosis of COVID-19 is not worse when accompanied by a psychiatric disorder. Laboratory assessment can guide clinicians to distinguish those infected with SARS-CoV-2 within psychiatric inpatient units. The biochemical assessment did not robustly support higher inflammatory levels in the comorbid COVID-19 and psychiatric disorder group compared to the COVID-19 group.

Keywords:
COVID-19
Psychiatric disorder
Inflammation
Psychotropic
Abbreviations:
Absolute neutrophil count
Alanine aminotransferase
Comorbidity
COVID-19 and psychiatric disorder group
C-reactive protein
Interleukin
Lactate dehydrogenase
Neutrophil/lymphocyte ratio
Polymerase Chain Reaction
Psychiatric disorder group
Systemic immune-inflammation index

Article

These are the options to access the full texts of the publication European Journal of Psychiatry
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos